Mustang Bio Announces Positive Opinion from the European Medicines Agency on Orphan Drug Designation for Its Lentiviral Gene Therapy for the Treatment of X-linked Severe Combined Immunodeficiency ("XSCID")
Stock Information for Mustang Bio Inc.
Loading
Please wait while we load your information from QuoteMedia.